HIV

Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Minyanville
Fri, 05/27/11 - 08:53 am
JNJ
Edurant
Zytiga
prostate cancer
HIV
AIDS
Ardea Biosciences Evenly Poised
Yahoo/Zacks.com
Wed, 05/25/11 - 09:50 am
Ardea
HIV
cancer
gout
J&J Approved, But Needs Help From a Friend
Motley Fool
Tue, 05/24/11 - 10:18 am
JNJ
HIV
Endurant
Gilead Sciences
Truvada
J&J AIDS Pill Signals $9 Billion in Revenue to Ease Recalls
Bloomberg
Mon, 05/23/11 - 11:37 am
HIV
AIDS
JNJ
Sangamo's Inevitable Acquisition/Merger
Seeking Alpha
Sun, 05/22/11 - 04:59 pm
Sangamo BioSciences
HIV
FDA approves new HIV drug from Johnson & Johnson
Yahoo/AP
Fri, 05/20/11 - 12:15 pm
HIV
FDA
JNJ
Edurant
Three Reasons That Big HIV Study May Be Less Important Than It Seems
Forbes
Sat, 05/14/11 - 12:49 pm
HIV
Novel Device Shows Promise for Reducing HIV Among Men
Thu, 05/12/11 - 07:29 pm
Novel Device
HIV
STD
Glaxo, Gilead AIDS Drugs Slash HIV Transmission by 96%
Bloomberg
Thu, 05/12/11 - 11:48 am
GSK
Gilead Sciences
AIDS
HIV
Report: GSK has no plans to sell HIV unit
Fierce Biotech
Fri, 05/6/11 - 10:04 am
HIV
M&A
GSK
ViiV Healthcare
Pfizer
Gilead AIDS prevention pill study halted; no benefit seen
Yahoo/AP
Mon, 04/18/11 - 11:01 am
Truvada
AIDS
Gilead Sciences
HIV
Abbott Agreed to Pay $52 Million to Resolve Aids Drug Case
Bloomberg
Sat, 04/16/11 - 01:28 pm
Norvir
HIV
Calif. officials seek lower prices for AIDS drugs
Yahoo/AP
Sat, 04/9/11 - 11:16 am
HIV
Gilead Sciences Raises Price Of Top Selling Products
Morningstar
Tue, 04/5/11 - 08:42 am
Gilead Sciences
drug pricing
HIV
Abbott Ordered to Pay Glaxo $3.5 Million in HIV Drug Suit
Bloomberg
Thu, 03/31/11 - 09:27 am
GSK
Abbott Laboratories
HIV
settlements
Norvir
First Chinese PDP Targets Tuberculosis, Malaria, AIDS
PharmExec
Thu, 03/24/11 - 04:23 pm
product developement partnership (PDP)
tuberculosis
malaria
HIV
Watson Launches Generic Famvir
Yahoo/Zacks
Thu, 03/24/11 - 03:10 pm
Watson Pharmaceuticals
Famvir
genital herpes
HIV
GILD's Elvitegravir Meets Study Goal
Yahoo/Zacks
Thu, 03/24/11 - 03:06 pm
Gilead Sciences
elvitegravir
HIV
Gilead HIV drug meets study goal
Yahoo/AP
Wed, 03/23/11 - 10:28 am
Gilead Sciences
HIV
elvitegravir
J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug
Bloomberg
Sat, 03/19/11 - 10:50 am
JNJ
Teva Pharmaceuticals
Prezista
HIV

Pages